Siteng Chen
Overview
Explore the profile of Siteng Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo T, Zhang X, Wang X, Tang H, Liu Y, Chen S, et al.
Int J Biol Sci
. 2024 Dec;
20(15):5925-5938.
PMID: 39664565
Immunotherapy is considered to be one of the most promising curative modalities for cancer, and the effectiveness of immunotherapy depends on the abundance of immune cells in the tumor microenvironment...
2.
Guo T, Chen J, Tan X, Tang H, Wang X, Chen S, et al.
Genes Immun
. 2024 Dec;
26(1):27-35.
PMID: 39639109
There are studies reporting that glucoside xylosyltransferase 2 (GXYLT2) has a role in promoting tumor progression, but its role in clear cell renal cell carcinoma (ccRCC) remains unclear. In this...
3.
Chen S, Wang X, Zhang J, Jiang L, Gao F, Xiang J, et al.
Pathology
. 2024 Aug;
56(7):951-960.
PMID: 39168777
There is an urgent clinical demand to explore novel diagnostic and prognostic biomarkers for renal cell carcinoma (RCC). We proposed deep learning-based artificial intelligence strategies. The study included 1752 whole...
4.
Gao F, Jiang L, Guo T, Lin J, Xu W, Yuan L, et al.
J Transl Med
. 2024 Jun;
22(1):568.
PMID: 38877591
Background: Metastasis renal cell carcinoma (RCC) patients have extremely high mortality rate. A predictive model for RCC micrometastasis based on pathomics could be beneficial for clinicians to make treatment decisions....
5.
Guo T, Wang X, Wang T, Zhang J, Liu Y, Chen S, et al.
Discov Oncol
. 2024 Jun;
15(1):205.
PMID: 38831128
The secretagogin (SCGN) was originally identified as a secreted calcium-binding protein present in the cytoplasm. Recent studies have found that SCGN has a close relationship with cancer. However, its role...
6.
Chen S, Gao F, Guo T, Jiang L, Zhang N, Wang X, et al.
Int J Surg
. 2024 Mar;
110(5):2970-2977.
PMID: 38445478
Background: Although separate analysis of individual factor can somewhat improve the prognostic performance, integration of multimodal information into a single signature is necessary to stratify patients with clear cell renal...
7.
Guo T, Zhang X, Chen S, Wang X, Wang X
Life Sci
. 2023 Dec;
336:122329.
PMID: 38052321
A variety of cancer cells exhibit dysregulated lipid metabolism, characterized by excessive intracellular lipid accumulation, and clear cell renal cell carcinoma (ccRCC) is the most typical disease with these characteristics....
8.
Chen S, Song D, Chen L, Guo T, Jiang B, Liu A, et al.
Precis Clin Med
. 2023 Nov;
6(3):pbad019.
PMID: 38025974
Due to the complicated histopathological characteristics of clear-cell renal-cell carcinoma (ccRCC), non-invasive prognosis before operative treatment is crucial in selecting the appropriate treatment. A total of 126 345 computerized tomography...
9.
Chen S, Zhang E, Guo T, Wang T, Chen J, Zhang N, et al.
J Cancer Res Clin Oncol
. 2023 Aug;
149(15):14283-14296.
PMID: 37558767
Background: The deep learning-based mA modification model for clinical prognosis prediction of patients with renal cell carcinoma (RCC) had not been reported for now. In addition, the important roles of...
10.
Chen G, Fan X, Wang T, Zhang E, Shao J, Chen S, et al.
Eur Radiol
. 2023 Jul;
33(12):8821-8832.
PMID: 37470826
Objectives: To construct and validate a prediction model based on full-sequence MRI for preoperatively evaluating the invasion depth of bladder cancer. Methods: A total of 445 patients with bladder cancer...